This is some blog description about this site

AntibioTx Initiates Grant-funded Project to Discover New Medicines Based on Screening Approach

AntibioTx has been rewarded a nondilutive grant from The Advanced Technology Foundation to discover and develop novel medicine on the basis of an advanced screening approach. The grant was rewarded to support lead identification and in vivo proof-of-concept studies.

Rasmus Toft-Kehler, CEO of AntibioTx, commented: “The support from The Advanced Technology Foundation allows us to pursue our dream of building the basis for a sustainable pharmaceutical company with a focus on developing novel treatments for patients with a significant unmet medical need” to which Dr. Morten Sommer, CSO of AntibioTx, further added: ”We are very excited to receive this funding because it really allows us to test the screening concept to discover new medicines for a variety of microbial diseases”.

The grant funding supports in vitro and in vivo work over a three-year period with the objective to identify and validate one or more novel candidates for further preclinical development.

This press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and can be identified by words such as committed, will, steps, may, can, portfolio, planned, advancing, look forward, expected, or similar words. These forward-looking statements are based upon current expectations, estimates, believed potentials and can, therefore, involve risks and uncertainties. Many of these risks and uncertainties can be difficult to predict and could be out of the control of AntibioTx A/S. We may not actually achieve our intended plans, and you should not place undue reliance on these forward-looking statements.

AntibioTx Rewarded Grant Funding to Conduct Phase ...